TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Novavax AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
831,037
|
1,486,017
|
956,587 |
Financial expenses |
688,978
|
730,503
|
418,227 |
Earnings before taxes |
197,440
|
490,161
|
-108,801 |
EBITDA |
226,686
|
507,948
|
-98,004 |
Total assets |
3,662,856
|
3,545,100
|
3,504,667 |
Current assets |
208,191
|
2,494,778
|
2,504,982 |
Current liabilities |
1,336,130
|
1,571,319
|
2,028,785 |
Equity capital |
2,326,726
|
1,973,781
|
1,475,882 |
- share capital |
51
|
47
|
49 |
Employees (average) |
195
|
167
|
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
63.5%
|
55.7%
|
42.1% |
Turnover per employee |
4,262
|
8,898 | |
Profit as a percentage of turnover |
23.8%
|
33.0%
|
-11.4% |
Return on assets (ROA) |
24.2%
|
34.4%
|
8.8% |
Current ratio |
15.6%
|
158.8%
|
123.5% |
Return on equity (ROE) |
8.5%
|
24.8%
|
-7.4% |
Change turnover |
-760,423
|
558,179
|
571,202 |
Change turnover % |
-48%
|
60%
|
148% |
Chg. No. of employees |
28
|
167
|
-57 |
Chg. No. of employees % | 17% | -100% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.